Search Results for: Schizophrenia

1632 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
ANXA1 and C14orf1 annexin A1 chromosome 14 open reading frame 1
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and KMT2B annexin A1 lysine (K)-specific methyltransferase 2B
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Chromatin modifying enzymes
  • Chromatin organization
  • PKMTs methylate histone lysines
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and UBE2I annexin A1 ubiquitin-conjugating enzyme E2I
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Post-translational protein modification
  • SUMOylation
  • Meiotic synapsis
  • Processing and activation of SUMO
  • SUMO is transferred from E1 to E2 (UBE2I, UBC9)
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and YWHAQ annexin A1 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Activation of BAD and translocation to mitochondria
  • Programmed Cell Death
  • Translocation of GLUT4 to the plasma membrane
  • Activation of BH3-only proteins
  • Intrinsic Pathway for Apoptosis
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and EGFR annexin A1 epidermal growth factor receptor
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Signaling by FGFR in disease
  • Signaling by EGFRvIII in Cancer
  • PLCG1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • DAP12 signaling
  • Downstream signaling events of B Cell Receptor (BCR)
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • PI3K/AKT activation
  • PI-3K cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Signaling by PDGF
  • EGFR downregulation
  • DAP12 interactions
  • GAB1 signalosome
  • GRB2 events in EGFR signaling
  • Signaling by ERBB4
  • Constitutive PI3K/AKT Signaling in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • PI3K events in ERBB4 signaling
  • EGFR interacts with phospholipase C-gamma
  • Signaling by ERBB2
  • Signaling by EGFR
  • Downstream signal transduction
  • Signaling by EGFR in Cancer
  • Fc epsilon receptor (FCERI) signaling
  • PI3K/AKT Signaling in Cancer
  • Adaptive Immune System
  • Axon guidance
  • PIP3 activates AKT signaling
  • L1CAM interactions
  • EGFR Transactivation by Gastrin
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • Downstream signaling of activated FGFR
  • Innate Immune System
  • Signalling by NGF
  • Signal transduction by L1
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Inhibition of Signaling by Overexpressed EGFR
  • Signaling by FGFR
  • SHC1 events in EGFR signaling
  • Constitutive Signaling by EGFRvIII
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
  • Cetuximab
  • Trastuzumab
  • Lidocaine
  • Gefitinib
  • Erlotinib
  • Lapatinib
  • Panitumumab
  • Flavopiridol
  • Vandetanib
  • S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE
  • N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE
  • Afatinib
ANXA1 and GAPDH annexin A1 glyceraldehyde-3-phosphate dehydrogenase
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Gluconeogenesis
  • Glucose metabolism
  • Myoclonic epilepsy of Lafora
  • Glycogen storage diseases
  • Glycolysis
  • Metabolism of carbohydrates
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
  • NADH
  • Nicotinamide-Adenine-Dinucleotide
  • Adenosine-5-Diphosphoribose
  • Thionicotinamide-Adenine-Dinucleotide
  • 4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE
ANXA1 and TRPM7 annexin A1 transient receptor potential cation channel, subfamily M, member 7
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Ion channel transport
  • TRP channels
  • Stimuli-sensing channels
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and UBE3A annexin A1 ubiquitin protein ligase E3A
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Class I MHC mediated antigen processing & presentation
  • Adaptive Immune System
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and MEIS2 annexin A1 Meis homeobox 2
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and UCHL5 annexin A1 ubiquitin carboxyl-terminal hydrolase L5
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Loss of Function of TGFBR2 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • Downregulation of TGF-beta receptor signaling
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • TGFBR1 KD Mutants in Cancer
  • TGF-beta receptor signaling activates SMADs
  • TGFBR1 LBD Mutants in Cancer
  • Loss of Function of TGFBR1 in Cancer
  • Signaling by TGF-beta Receptor Complex
  • Signaling by TGF-beta Receptor Complex in Cancer
  • SMAD4 MH2 Domain Mutants in Cancer
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and CSAD annexin A1 cysteine sulfinic acid decarboxylase
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Degradation of cysteine and homocysteine
  • Sulfur amino acid metabolism
  • Metabolism of amino acids and derivatives
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
  • Pyridoxal Phosphate
  • L-Cysteine
ANXA1 and FPR1 annexin A1 formyl peptide receptor 1
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Class A/1 (Rhodopsin-like receptors)
  • G alpha (i) signalling events
  • Metabolic disorders of biological oxidation enzymes
  • GPCR ligand binding
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
  • Nedocromil
ANXA1 and SRC annexin A1 SRC proto-oncogene, non-receptor tyrosine kinase
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Signaling by ERBB2
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
  • Dasatinib
  • RU84687
  • RU79256
  • N6-Benzyl Adenosine-5\'-Diphosphate
  • RU85493
  • RU78262
  • Phosphonotyrosine
  • Malonic acid
  • RU83876
  • RU90395
  • RU79072
  • RU78783
  • 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
  • PASBN
  • RU82129
  • PAS219
  • DPI59
  • RU82197
  • Phenylphosphate
  • RU78300
  • RU79073
  • RU82209
  • ISO24
  • RU85053
  • RU78299
  • Oxalic Acid
  • RU78191
  • Citric Acid
  • RU81843
  • 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
  • Purvalanol A
  • Bosutinib
  • 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea
  • 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea
  • 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL
  • N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE
  • [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile
  • 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  • 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  • 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  • 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE
  • N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE
  • (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide
  • Ponatinib
ANXA1 and OTUB1 annexin A1 OTU deubiquitinase, ubiquitin aldehyde binding 1
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and KLHL23 annexin A1 kelch-like family member 23
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and APBB1 annexin A1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and C1orf123 annexin A1 chromosome 1 open reading frame 123
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and CCT7 annexin A1 chaperonin containing TCP1, subunit 7 (eta)
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Protein folding
  • Prefoldin mediated transfer of substrate to CCT/TriC
  • Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding
  • Association of TriC/CCT with target proteins during biosynthesis
  • Chaperonin-mediated protein folding
  • Formation of tubulin folding intermediates by CCT/TriC
  • Folding of actin by CCT/TriC
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and PRKCI annexin A1 protein kinase C, iota
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Cell junction organization
  • Cell-cell junction organization
  • Signalling by NGF
  • p75NTR recruits signalling complexes
  • Tight junction interactions
  • p75NTR signals via NF-kB
  • p75 NTR receptor-mediated signalling
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and DYSF annexin A1 dysferlin
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone

Page 4 out of 82 pages